Jennifer T. Wells, Adnan Said, Rashmi Agni, Santiago Tome, Sarah Hughes, Parul Dureja, Michael R. Lucey – 28 November 2007 – Patients with clinical acute alcoholic hepatitis (AAH) are not considered suitable candidates for orthotopic liver transplantation (OLT). The histological correlates of AAH are often seen in the explanted liver at the time of transplantation. The importance of these findings remains inconclusive regarding their role as a prognostic marker for patient or allograft health.

Ragai R. Mitry, Ruth De Bruyne, Alberto Quaglia, Robin D. Hughes, Anil Dhawan – 28 November 2007

John C. Hoefs, Timothy R. Morgan – 28 November 2007

Pere Ginès, Mónica Guevara – 28 November 2007

Matteo Cescon, Gian Luca Grazi, Matteo Ravaioli, Alessandro Cucchetti, Giorgio Ercolani, Antonio Daniele Pinna – 28 November 2007

Michitaka Ozaki, Satoru Todo – 28 November 2007

Matteo Ravaioli, Matteo Cescon, Elisa Mikus, Gian Luca Grazi, Giorgio Ercolani, Takuya Kimura, Francesco Tuci, Piero Maria Mikus, Mauro Bernardi, Antonio Daniele Pinna – 28 November 2007

John G. Lunz, Susan M. Specht, Noriko Murase, Kumiko Isse, Anthony J. Demetris – 28 November 2007 – Intraorgan dendritic cells (DCs) monitor the environment and help translate triggers of innate immunity into adaptive immune responses. Liver‐based DCs are continually exposed, via gut‐derived portal venous blood, to potential antigens and bacterial products that can trigger innate immunity. However, somehow the liver avoids a state of perpetual inflammation and protects central immune organs from overstimulation.

Sanaa M. Kamal, Samer S. El Kamary, Michelle D. Shardell, Mohamed Hashem, Imad N. Ahmed, Mohamed Muhammadi, Khalifa Sayed, Ashraf Moustafa, Sarah Abdel Hakem, Amany Ibrahiem, Mohamed Moniem, Hoda Mansour, Mohamed Abdelaziz – 28 November 2007 – In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined.

Fasiha Kanwal, Tuyen Hoang, Brennan M.R. Spiegel, Seth Eisen, Jason A. Dominitz, Allen Gifford, Mathew Goetz, Steven M. Asch – 28 November 2007 – Treatment with interferon and ribavirin is effective in patients with chronic infection with hepatitis C virus (HCV). Previous data indicate that treatment rates are suboptimal. We sought to identify patient and provider‐level predictors of treatment receipt in HCV by conducting a retrospective cohort study of 5701 HCV patients in a large regional Veteran's Administration (VA) healthcare network.